Atlas Private Wealth Management Boosts Stock Holdings in UnitedHealth Group Inc (NYSE:UNH)
Atlas Private Wealth Management lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 11.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,175 shares of the healthcare conglomerate’s stock after purchasing an additional 624 shares during the period. UnitedHealth Group accounts for approximately 1.4% of Atlas Private Wealth Management’s portfolio, making the stock its 16th largest position. Atlas Private Wealth Management’s holdings in UnitedHealth Group were worth $1,540,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Tobias Financial Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. RMR Wealth Builders bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. HBC Financial Services PLLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Country Trust Bank increased its stake in shares of UnitedHealth Group by 556.3% during the first quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 89 shares in the last quarter. Finally, Total Clarity Wealth Management Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 86.48% of the company’s stock.
A number of equities analysts have weighed in on UNH shares. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Citigroup decreased their price target on UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research note on Friday, April 24th. SunTrust Banks increased their target price on UnitedHealth Group from $340.00 to $360.00 and gave the company a “buy” rating in a report on Thursday, May 21st. Stephens increased their target price on UnitedHealth Group from $300.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 15th. Finally, Deutsche Bank dropped their price target on UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research note on Thursday, April 16th. Four research analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $319.68.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, topping the Zacks’ consensus estimate of $3.63 by $0.09. The firm had revenue of $64.40 billion for the quarter, compared to analysts’ expectations of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $3.73 earnings per share. On average, research analysts forecast that UnitedHealth Group Inc will post 16.24 earnings per share for the current year.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $228.39, for a total transaction of $2,283,900.00. Following the transaction, the director now directly owns 158,598 shares in the company, valued at approximately $36,222,197.22. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 45,637 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the transaction, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 65,637 shares of company stock worth $17,723,013. Company insiders own 0.80% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Percentage Gainers
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.